Lisata Therapeutics Inc
F:8NE
Lisata Therapeutics Inc
F:8NE
Price:
3.02
EUR
-1.31%
Market Cap:
€25.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Lisata Therapeutics Inc
F:8NE
|
US |
|
Ovintiv Inc
NYSE:OVV
|
US |
|
Nomura Research Institute Ltd
OTC:NRILY
|
JP |
|
Bevcanna Enterprises Inc
F:7BC
|
CA |
|
Triputra Agro Persada Tbk PT
IDX:TAPG
|
ID |
|
MS&AD Insurance Group Holdings Inc
F:59M0
|
JP |
|
F
|
First Graphene Ltd
OTC:FGPHF
|
AU |
|
C
|
Cardinal Infrastructure Group Inc
NASDAQ:CDNL
|
US |
|
SBI Holdings Inc
F:ZOF
|
JP |
|
P
|
Proximus NV
DUS:BX7
|
BE |
|
H
|
Hochtief AG
F:HOT
|
DE |
|
T
|
TC Energy Corp
SWB:TRS
|
CA |
|
N
|
Neogenomics Inc
F:NG9
|
US |
|
LendLease Group
ASX:LLC
|
AU |
|
Celularity Inc
NASDAQ:CELU
|
US |
|
D
|
Delek US Holdings Inc
F:DEH
|
US |
|
N
|
Nokia Oyj
F:NOA3
|
FI |
|
R
|
Roper Technologies Inc
F:ROP
|
US |
|
Vetoquinol SA
PAR:VETO
|
FR |
|
Carbios SA
F:3C1
|
FR |
|
G
|
Green Plains Inc
F:G3V
|
US |
DCF Valuation
is not available for Lisata Therapeutics Inc
is not available for Lisata Therapeutics Inc
8NE's DCF value cannot be reliably calculated.
Switch to
Continue 8NE Research
Other Lisata Therapeutics Inc listings:
Discover More
